Drug

Business roundup: U.S. to ramp up generics; TKMS withdraws Kiel offer; Novo Nordisk sues Eli Lilly; Indian group eyes VW unit stake Business roundup: U.S. moves to boost generic drug …

Yosemite venture firm closes first close of second fund, eyes AI-driven oncology breakthroughs Yosemite venture firm secures first close of a $350M-target fund, using AI and philanthropy to build oncology …

Daiichi Sankyo Pfaffenhofen investment: Japanese pharma confirms €1 billion expansion in Bavaria Daiichi Sankyo confirms €1 billion investment to expand its Pfaffenhofen cancer drug site in Bavaria, keeping plans despite …

U.S. launches Section 301 probe into German drug pricing, raising tariff threat to pharma U.S. opens Section 301 probe into German drug pricing, examining whether Germany underpays innovative medicines; tariffs …

Cologne and Düsseldorf Mayors Propose Pilot to Tolerate Micro-Dealing in Supervised Drug Consumption Rooms Cologne and Düsseldorf mayors seek a pilot to tolerate micro-dealing inside supervised drug consumption rooms, citing …

U.S. Launches Trade Investigation into German Drug Prices Under Section 301 U.S. opens a Section 301 trade investigation into German drug prices, probing whether Germany underpays for innovative medicines—possible tariffs …

NVision raises $55 million to scale quantum platform for drug discovery NVision raises $55 million to expand its quantum platform from sensing to computing, accelerating MRI-based diagnostics and drug discovery …

German cabinet advances five-year minimum for rape involving knockout drops German cabinet advances law to impose a five-year minimum sentence for rape involving knockout drops, Justice Minister Stefanie Hubig said …

Jordan strikes in Syria hit alleged weapons and drug depots, Amman says Jordan strikes in Syria hit alleged weapons and drug depots near Suweida and Arman; Amman calls it a …